Risk factors for recurrence of Crohn's disease requiring surgery in patients receiving post-operative anti-tumor necrosis factor maintenance therapy
Author:
Affiliation:
1. Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine
Publisher
The Japan Society of Coloproctology
Link
https://www.jstage.jst.go.jp/article/jarc/1/1/1_2016-004/_pdf
Reference29 articles.
1. 1. Sachar DB. The problem of postoperative recurrence of Crohns disease. Med Clin North Am. 1990 Jan;74 (1):183-8.
2. 2. Mekhjian HS, Switz DM, Watts HD, et al. National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology. 1979 Oct;77 (4 Pt 2):907-13.
3. 3. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010 Sep;59 (9):1200-6.
4. 4. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009 Feb;136 (2):441-50.
5. 5. Sorrentino D, Paviotti A, Fiorino G. Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. Curr Drug Targets. 2010 Feb;11 (2):219-26.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease;Drugs;2023-07-28
2. The advanced lung cancer inflammation index predicts outcomes in patients with Crohn’s disease after surgical resection;Colorectal Disease;2020-08-11
3. A series of seton techniques involving "top-down therapy" for patients with Crohn's disease who initially presented with perianal fistulas;Journal of the Anus, Rectum and Colon;2018-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3